Envoy Medical, Inc.
COCH
$1.37
$0.064.58%
| Weiss Ratings | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.10 | |||
| Price History | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.18% | |||
| 30-Day Total Return | -7.43% | |||
| 60-Day Total Return | -11.61% | |||
| 90-Day Total Return | -32.84% | |||
| Year to Date Total Return | -11.04% | |||
| 1-Year Total Return | -69.42% | |||
| 2-Year Total Return | -86.29% | |||
| 3-Year Total Return | -86.01% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -81.81% | |||
| 52-Week Low % Change | 8.26% | |||
| Price | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $7.20 | |||
| 52-Week Low Price | $1.21 | |||
| 52-Week Low Price (Date) | Jan 15, 2025 | |||
| 52-Week High Price (Date) | Apr 05, 2024 | |||
| Valuation | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 27.89M | |||
| Enterprise Value | 42.07M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.28 | |||
| Earnings Per Share Growth | -64.64% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 92.91 | |||
| Price/Book (Q) | -1.39 | |||
| Enterprise Value/Revenue (TTM) | 151.34 | |||
| Price | $1.37 | |||
| Enterprise Value/EBITDA (TTM) | -1.98 | |||
| Enterprise Value/EBIT | -1.96 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 19.62M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -8.70% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 877 900 3277 | |||
| Address | 4875 White Bear Parkway White Bear Lake, MN 55110 | |||
| Website | www.envoymedical.com | |||
| Country | United States | |||
| Year Founded | 1995 | |||
| Profitability | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -7,721.94% | |||
| Profit Margin | -7,574.82% | |||
| Management Effectiveness | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -87.66% | |||
| Return on Equity | -- | |||
| Income Statement | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 278.00K | |||
| Total Revenue (TTM) | 278.00K | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | -541.00K | |||
| EBITDA (TTM) | -21.29M | |||
| EBIT (TTM) | -21.47M | |||
| Net Income (TTM) | -21.06M | |||
| Net Income Avl. to Common (TTM) | -22.89M | |||
| Total Revenue Growth (Q YOY) | -30.00% | |||
| Earnings Growth (Q YOY) | -481.32% | |||
| EPS Diluted (TTM) | -1.28 | |||
| EPS Diluted Growth (Q YOY) | -398.88% | |||
| Balance Sheet | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.42M | |||
| Cash Per Share (Q) | $0.23 | |||
| Total Current Assets (Q) | 7.14M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -18.53M | |||
| Current Ratio (Q) | 0.786 | |||
| Book Value Per Share (Q) | -$0.94 | |||
| Total Assets (Q) | 9.40M | |||
| Total Current Liabilities (Q) | 9.07M | |||
| Total Debt (Q) | 15.61M | |||
| Total Liabilities (Q) | 27.93M | |||
| Total Common Equity (Q) | -18.53M | |||
| Cash Flow | COCH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.54M | |||
| Cash from Financing (TTM) | 14.39M | |||
| Net Change in Cash (TTM) | -12.42M | |||
| Levered Free Cash Flow (TTM) | -6.57M | |||
| Cash from Operations (TTM) | -25.27M | |||
